ES455478A1 - Disodium chromoglycate and pharmaceutical composition containing same - Google Patents

Disodium chromoglycate and pharmaceutical composition containing same

Info

Publication number
ES455478A1
ES455478A1 ES455478A ES455478A ES455478A1 ES 455478 A1 ES455478 A1 ES 455478A1 ES 455478 A ES455478 A ES 455478A ES 455478 A ES455478 A ES 455478A ES 455478 A1 ES455478 A1 ES 455478A1
Authority
ES
Spain
Prior art keywords
pharmaceutical composition
composition containing
containing same
pref
microns
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES455478A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Ltd
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26238506&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES455478(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB3672/76A external-priority patent/GB1562901A/en
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of ES455478A1 publication Critical patent/ES455478A1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Cosmetics (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Disodium cromoglycate (I) is characterised in that it contains 5 (pref. 0.05-1) wt% of water. The lower moisture content (I) allows easier operation of valves (in pressurised containers) and reduces losses of propellant when filling the containers. Pref. (I) is finely divided having an average diameter 20 microns, pref. 0.01-10 microns and esp. where at least 50 wt% have a diameter of 2-5 microns.
ES455478A 1976-01-30 1977-01-29 Disodium chromoglycate and pharmaceutical composition containing same Expired ES455478A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB3672/76A GB1562901A (en) 1976-01-30 1976-01-30 Disodium cromoglycate
GB5113676 1976-12-08

Publications (1)

Publication Number Publication Date
ES455478A1 true ES455478A1 (en) 1978-02-01

Family

ID=26238506

Family Applications (1)

Application Number Title Priority Date Filing Date
ES455478A Expired ES455478A1 (en) 1976-01-30 1977-01-29 Disodium chromoglycate and pharmaceutical composition containing same

Country Status (14)

Country Link
JP (1) JPS5294411A (en)
AU (1) AU512593B2 (en)
DE (1) DE2703119A1 (en)
DK (2) DK154766C (en)
ES (1) ES455478A1 (en)
FI (1) FI770215A (en)
FR (1) FR2339604A1 (en)
IE (1) IE44760B1 (en)
IL (1) IL51314A (en)
LU (1) LU76661A1 (en)
NL (1) NL185446C (en)
NO (2) NO151860C (en)
NZ (1) NZ183157A (en)
SE (2) SE442268B (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU522792B2 (en) * 1977-07-19 1982-06-24 Fisons Plc Pressure pack formulation
CY1333A (en) * 1980-04-30 1986-10-24 Fisons Ltd Pharmaceutical compositions containing cromoglycates
ZA812811B (en) * 1980-04-30 1982-06-30 Fisons Ltd Mixtures and salts of beta-2 selective bronchodilators with cromoglycic acid and salts thereof
JPS63138228U (en) * 1987-03-05 1988-09-12
JPS63138229U (en) * 1987-03-05 1988-09-12
GB8819490D0 (en) * 1988-08-16 1988-09-21 Fisons Plc Pharmaceutical devices
DE68915203T2 (en) * 1988-03-22 1994-09-22 Fisons Plc Pharmaceutical blends.
GB8829478D0 (en) * 1988-12-16 1989-02-01 Harris Pharma Ltd Formulations
DE4003270A1 (en) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg NEW SPEED GASES AND THEIR USE IN MEDICINE PREPARATIONS
ATE128350T1 (en) * 1991-12-12 1995-10-15 Glaxo Group Ltd PHARMACEUTICAL AEROSOL FORMULATION.
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
US5744123A (en) * 1991-12-12 1998-04-28 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US5653962A (en) * 1991-12-12 1997-08-05 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
US5916540A (en) * 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
AU663905B2 (en) 1991-12-12 1995-10-26 Glaxo Group Limited Medicaments
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
ATE150296T1 (en) 1991-12-18 1997-04-15 Minnesota Mining & Mfg AEROSOL COMPOSITIONS FOR MEDICINAL SUSPENSIONS
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
EP1100465B1 (en) 1998-07-24 2004-11-24 Jago Research Ag Medicinal aerosol formulations
US6475467B1 (en) 1998-08-04 2002-11-05 Jago Research Ag Medicinal aerosol formulations
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
EP2425820B1 (en) 2007-02-11 2015-04-08 MAP Pharmaceuticals Inc Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE555319A (en) * 1956-03-21 1900-01-01
BE556587A (en) * 1957-01-31 1957-04-11
GB1063512A (en) * 1962-11-30 1967-03-30 Benger Lab Ltd Aerosols
US3282791A (en) * 1965-08-17 1966-11-01 Merck & Co Inc Inhalation aerosol suspension of anhydrous disodium dexamethasone phosphate, propellents, and sorbitan trioleate
GB1242211A (en) * 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
IL44022A0 (en) * 1973-01-23 1974-05-16 Fisons Ltd Novel salts of anti-inflammatory quinoline derivatives,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
NZ183157A (en) 1979-08-31
IL51314A (en) 1980-03-31
DK357588D0 (en) 1988-06-29
AU512593B2 (en) 1980-10-16
IE44760L (en) 1977-07-30
DK357588A (en) 1988-06-29
DK154766C (en) 1989-05-22
SE442268B (en) 1985-12-16
SE8107278L (en) 1981-12-04
AU2162677A (en) 1978-08-03
DK38077A (en) 1977-07-31
NL185446B (en) 1989-11-16
SE7700888L (en) 1977-07-31
NO151860C (en) 1985-06-19
JPS5294411A (en) 1977-08-09
DE2703119C2 (en) 1990-10-25
IL51314A0 (en) 1977-03-31
SE442267B (en) 1985-12-16
DE2703119A1 (en) 1977-08-04
IE44760B1 (en) 1982-03-24
FI770215A (en) 1977-07-31
JPS6129929B2 (en) 1986-07-10
NO770286L (en) 1977-08-02
NO151860B (en) 1985-03-11
DK154766B (en) 1988-12-19
FR2339604B1 (en) 1980-12-05
DK156876C (en) 1990-03-12
NL7700911A (en) 1977-08-02
LU76661A1 (en) 1977-08-03
DK156876B (en) 1989-10-16
FR2339604A1 (en) 1977-08-26
NL185446C (en) 1990-04-17
NO780183L (en) 1977-08-02

Similar Documents

Publication Publication Date Title
ES455478A1 (en) Disodium chromoglycate and pharmaceutical composition containing same
ATE37652T1 (en) COCOA POWDER.
DE3067351D1 (en) Dentifrice with high foaming ability
FR2047250A5 (en) Protective atmosphere for casting mg and mg - alloy
GB1352968A (en) Odorant and or flavorant
JPS5217992A (en) Chip compression packing method and its device
JPS5266887A (en) Defoaming agent composition
JPS5346232A (en) Quantizing circuit
JPS51131909A (en) Sprayer
JPS5232444A (en) Slidable bearing
JPS5228505A (en) Method for filling edible oil
JPS5215967A (en) Fail safe servo-control valve
JPS5336546A (en) Stabilized rubber composition
JPS5231925A (en) Contact chip
JPS5323792A (en) Packing method by injecting/blowing synthetic resin
USD220723S (en) Radio receiver
DE3562782D1 (en) Flexible containers containing a liquid product and prevention of vacuum collapse therein
DE3761550D1 (en) PACKING CONTAINING A WATER-IN-OIL FAT DISPERSION AND THEIR PRODUCTION METHOD.
JPS5214908A (en) Capacity controlling device in screw compressor
JPS52123084A (en) Method of loading powder freight in hold
Achenbach et al. Investigation on metabolites of microorganisms. XXVII. Cyclopaldic acid and 3-O-methyl cyclopolic acid, two antibiotically active substances from Aspergillus duricaulis.
JPS51118582A (en) Breaking device for packages
JPS51139485A (en) Full automatic method of filling packag with inert gas
JPS5329308A (en) Oxidation of mineral oil
Masek Degassing of Pit Coal and Pitch in Reducing, Inert or Oxidizing Atmospheres